For over 20 years our clinical hospital admits neurological and oncological patients from all parts of the world for diagnostics and therapy. In most cases these patients cannot be helped by conventional methods of treatment and rehabilitation. All these years we have been developing individually tailored innovative medical biotechnologies and novel protocols in the area of molecular (genome and post-genome) and regenerative medicine, many of which are unparalleled in the world. Such technologies as ultra-early post-genome diagnostics of cancer and neurodegenerative diseases with artificial intelligence, remote controlled multi-wave radioneuroengineering of the brain, tissue engineering of the spinal cord, anti-cancer molecularly targeted cell preparations, biological highly technological cell-based pharmaceuticals, neurodegenerative biomedical cell products are patented in the Russian Federation and abroad and serve our business card in Russia and in the world. Back in 2005 we officially registered the cell technologies of the injured brain and spinal cord in the Roszdravnadzor; these technologies have acquired the status of medical technologies and approved for clinical application in Russia. Over 10 000 patients received the therapy of severe consequences of neural traumas and over 25000 injections of cell preparations have been administered to enhance the efficiency of rehabilitation almost in 61%. Our recent advance and an academic breakthrough are ex vivo gene therapy of orphan (rare) hereditary neural and neurodegenerative diseases that has been developed in cooperation with Novosibirsk geneticists and Moscow molecular biologist.